AI assistant
Aarti Drugs Limited — Call Transcript 2023
Apr 27, 2023
62194_rns_2023-04-27_f7152990-c4c9-46f9-8a99-7763daa030ca.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [512 x 106] intentionally omitted <==
Ref: ADL/SE/2023-24/09 April 27, 2023
To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348
Dear Sir/Madam,
Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call
This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Tuesday, May 02, 2023 at 10:00 A.M. IST to discuss the Company’s financial performance for the Quarter and year ended March 31, 2023. Please find attached herewith invitation for the same.
Kindly take the same on record.
Thanking you,
Yours faithfully,
FOR AARTI DRUGS LIMITED
RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2023.04.27 20:24:34 +05'30'
RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527
==> picture [468 x 29] intentionally omitted <==
==> picture [117 x 54] intentionally omitted <==
Aarti Drugs Limited
Cordially invites you to
Conference Call
To discuss the financial performance for the Quarter and Financial Year ended 31[st] March, 2023
Day/Date : Tuesday, 02[nd] May, 2023 Time : 10:00 AM, IST
Diamond Pass : Please Click here to express join the Call
| Primary Number: | +91 226280 1309 |
| +91 22 7115 8210 | |
| Toll Free Number: | Hongkong– 800964448 |
| Singapore– 8001012045 | |
| UK– 08081011573 | |
| US– 18667462133 |
Participants:
Mr. Harshit Savla – Jt. Managing Director
Mr. Harit Shah – Wholetime Director
Mr. Adhish Patil – Chief Finance Officer
Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited
We look forward to your participation
RSVP
Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296